Table 3.
Overall responses in 144 patients treated with tumor infiltrating lymphocytes.*
| Outcome | Stage M1c - no brain metastases (n=111) | Stage M1c - treated brain metastases (n=15) | Stage M1c - untreated brain metastases (n=18) |
|---|---|---|---|
| Progressive disease | 56 (50%) | 10 (67%) | 12 (67%) |
| Stable disease | 1 (1%) | 0 (0%) | 0 (0%) |
| Partial response | 31 (28%) | 4 (26%) | 6 (33%) |
| Ongoing | 10 | 1 | 1 |
| Complete response | 23 (21%) | 1 (7%) | 0 (0%) |
| Ongoing | 22 | 0 | 0 |
by RECIST criteria